SPA Flashcards
13(1)(a)
Patentable invention: novelty
13(1)(b)
Patentable invention: inventive step
13(1)(c)
Patentable invention: industrial application
13(2)
Non-patentable invention: encourage offensive, immoral or anti-social behaviours
13(3)
Non-patentable invention: subject-matter probihited by the law may not necessarily fall under 12(2)
14(1)
Invention is new if it does not form part of the state of the art
14(2)
state of the art: made available to the public globally before pirority date of the invention
14(3)
state of the art exception: earlier SG!!! application published after priority date of this invention, and contain the same subject matter when filed and published, considered for novelty but not inventive step evaluation
always check if the prior art is validly entitled to the earliest priority date
14(4)
12 months grace period: matter made avialable to the public is excluded from the SOTA:
(a) info was disclosed unlawfully or in breach of confidence;
(b) disclosed due to breach of confidence;
(c) inventor displaying the invention as an international exhibition;
(d) paper read before learned society or published in the transactions of any learned society; or
(e) subject to subsections (6) and (7), disclosed by inventor or person obtained the info from the inventor in circumstances not mentioned in (a) to (d)
14(5)
defined learned society as aiming to promote learning or science
14(6)
patent application may be disregarded if
(a) it was filed without the consent of the inventor; or
(b) the publication should not have happended as the application had been withdrawn/refused/abandoned before publication
14(7)
If publication was earlier than it should be by law, the publication date used to judge the 12-month grace period should be the by-right publication date
14(8)
To disregard any prior art at requesting exam, a written evidence is required to be filed
14(9)
whichever applies to the inventor in s14 applies to the applicant
14(10)
Allow new medical uses of known substances, whether it is 1st or 2nd MU. 1st MU is also a purpose-limited product claim, while Swiss-type is a purpose-limited process claim
15
Inventive step: no obvious to a PSA, s14(3) not considered to IS assessment (i.e., it is possible to have claims not novel but inventive)
16(2)
MOT of human or animal body by surgery, therapy or diagnosis is not taken to be capable of industrial application
16(3)
Allow product for treating diseases to be patentable subject matter (e.g., 1st MU, Swiss-type 2nd MU). Supplemented by s14(10)
17(1)
Priority date of an invention is the date of filing the application.
17(2)
Claiming the date of filing of the earliest priority document disclosing the same (a) invention or (b) matter, the request needs to be made by the same applicant or predecessor in title of the applicant
17(3)(a)
Priority declaration to be within 12 months after date of filing. (unless request is filed under s17(4) to declare priority within 14 months)
17(4)
request to Registrar to claim priority after the normal 12 months period
17(5)
request for late declaration needs to show (a) due care has been taken OR (b) unintentional
19(1)
Any person(s) may make an application for a patent